WASHINGTON, Aug. 8, 2017 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against NxStage Medical, Inc. (NASDAQ: NXTM) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Fresenius Medical Care for $30.00 per share in cash. The transaction is valued at approximately $2 billion and is expected to close in 2018.
If you are a NxStage Medical, Inc. shareholder and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/nxstage. You may also contact Danielle Rowland Lindahl, Esq. at Rowley Law PLLC, 2316 Rhode Island Ave NE, Washington, DC 20018, by email at email@example.com, or by telephone at 202-800-3501 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC